Concerns around potential side effects are a known reason people choose not to take GLP-1 drugs
Preclinical results in murine models treated with GLP-1RAs suggest that the potential effects of semaglutide in AD may be exerted via impact on several AD-related pathophysiologic processes including neuroinflammatory pathways, vascular and BBB integrity, reduced synaptic loss, and neuroprotection [19, 21, 23,24,25,26, 46,47,48]
Most digestive side effects are worst in the first 2-4 weeks after starting the medication or increasing the dose
Our team prioritizes personalized care, and works closely with our patients to determine the most suitable weight loss strategies
Participants prescribed a reduced-calorie diet, increased physical activity, and monthly nutritional counseling
In fact, Hamilton says, MASH is the leading cause of liver transplants among women in the United States